RESUMEN
Neuronal nicotinic acetylcholine receptors (nAChRs) containing alpha7 subunit are well represented in the brain and some non-neuronal tissues, and their malfunctioning is associated with diverse pathologies. Therefore, detection and quantification of alpha7 nAChR are important tasks. The affinity-purified antibodies were prepared against the 1-23 and 179-190 fragments of the human and rat alpha7 nAChR extracellular domain. The specificity and selectivity of these alpha7 (1-23) and alpha7 (179-190) antibodies was tested by ELISA in model systems: the E. coli-expressed alpha7 subunit extracellular domain and the pituitary cell line GH(4)C(1) stably expressing human alpha7 nAChR. On the rat brain slices two antibodies and biotinylated alpha-cobratoxin specifically stained the hippocampus region known to be rich in alpha7 nAChR. Western blot analysis revealed that in the human thalamus membranes and in rat brain membranes, antibodies alpha7 (1-23) stained a single band of 62 kDa, while the alpha7 (179-190) antibodies stained a doublet of 53-54 kDa. The results obtained show that utilization of model systems and a combination of several antibodies with appropriately labeled toxins may provide better ways for detection of alpha7 nAChR.
Asunto(s)
Anticuerpos/inmunología , Proteínas Neurotóxicas de Elápidos/química , Receptores Nicotínicos/análisis , Animales , Afinidad de Anticuerpos/inmunología , Biotinilación , Química Encefálica , Ensayo de Inmunoadsorción Enzimática/métodos , Hipocampo/química , Humanos , Peso Molecular , Fragmentos de Péptidos/química , Fragmentos de Péptidos/inmunología , Ratas , Receptores Nicotínicos/química , Receptores Nicotínicos/inmunología , Reproducibilidad de los Resultados , Tálamo/química , Receptor Nicotínico de Acetilcolina alfa 7RESUMEN
Using immunoenzymic assays, the authors studied concentrations of two isoforms of the glycolytic enzyme enolase (neurospecific, NSE, and non-neurospecific, NNE) in different structures of the postmortem brain in mentally normal people (n = 15) and in schizophrenics (n = 9). In schizophrenic patients NSE concentrations were increased by 70% (p less than 0.001) in the sensory cortex and reduced by the same magnitude in the thalamus. Insignificant changes in their levels (by 15-20%, p less than 0.05) were also discovered in the temporal cortex (elevation), lymbic cortex and the hippocampus (decrease). Cerebral values of NNE in schizophrenic patients were virtually unaltered; a certain augmentation was detected only in the hippocampus. It is supposed that marked changes in NSE concentrations in the sensory cortex and in the thalamus are probably related to the pathological processes occurring in the neural tissue in schizophrenia.